scispace - formally typeset
Open AccessJournal ArticleDOI

Effects of verapamil on myocardial performance in coronary disease.

Jack Ferlinz, +2 more
- 01 Feb 1979 - 
- Vol. 59, Iss: 2, pp 313-319
Reads0
Chats0
TLDR
In patients with CAD, the intrinsic negative inotropic effect of verapamil is of negligible importance because its potent vasodilatory properties more than compensate for any intrinsic decrease in LV contractility, and thereby improve the overall cardiac function.
Abstract
Verapamil, a calcium antagonist, has been used extensively for treatment of cardiac arrhythmias. Concern persists, however, that it may seriously depress myocardial function in cardiac patients. To investigate this possibility, 20 patients with coronary artery disease (CAD) but no heart failure were given intravenous verapamil (0.1 mg/kg bolus, followed by 0.005 mg/kg/min infusion), and studied hemodynamically and angiographically. Verapamil markedly lowered mean aortic pressure (94 +/- 17 to 82 +/- 13 mm Hg, p less than 0.0005) and systemic vascular resistance (1413 +/- 429 to 1069 +/- 235 dyn-sec-cm5, p less than 0.0005). Simultaneously, all indices of left ventricular (LV) performance greatly improved: cardiac index rose from 2.8 +/- 0.6 to 3.1 +/- 0.7 1/min/m2 (p less than 0.0005), mean velocity of circumferential fiber shortening increased from 0.85 +/- 0.39 to 0.97 +/- 0.46 circ/sec (p less than 0.01), and ejection fraction improved from 55 +/- 16 to 61 +/- 18% (p less than 0.01). No significant cha...

read more

Citations
More filters
Journal ArticleDOI

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

TL;DR: Nifedipine is a potent, long-acting vasodilator that has proved highly efficacious in relieving anginal symptoms caused by coronary vasospasm, and its value as an antiarrhythmic agent remains to be delineated.
Journal ArticleDOI

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications

TL;DR: The negative inotropic effects of verapamil are valuable in improving the symptoms and hemodynamic disturbances of hypertrophic cardiomyopathy and the role of these agents in treating arterial hypertension, unstable angina pectoris, acute myocardial infarction, and ischemia during cardiopulmonary bypass needs to be determined.
Journal ArticleDOI

Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

TL;DR: Evidence from clinical studies supports the role of oral verapamil as an effective and well-tolerated first-line treatment for the management of patients with mild to moderate essential hypertension and it may be used in preference to beta-blockers in patients with asthma or chronic obstructive airway disease.
Journal ArticleDOI

Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.

TL;DR: Evidence indicates that certain slow-channel antagonists may be useful in other cardiocirculatory disorders, such as acute pulmonary edema, acute hypertensive emergencies and obstructive cardiomyopathies, whose indications, if confirmed, will broaden the clinical usefulness of this class of compounds.
Journal ArticleDOI

Wide Complex Tachycardia: Misdiagnosis and Outcome After Emergent Therapy

TL;DR: The extent and consequence of misdiagnosis of wide complex tachycardia (QRS, 120 ms or more; heart rate, 100 or more beats/min) presenting emergently were assessed and Verapamil is commonly administered in these circumstances and is frequently associated with a poor outcome.
References
More filters
Journal ArticleDOI

Physiologic basis for assessing critical coronary stenosis : Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve

TL;DR: Flow response and regional distribution during coronary hyperemia caused by Hypaque are quantitative measures for physiologically assessing critical coronary stenosis and flow reserve with potential applicability to patients.
Journal ArticleDOI

Localized disorders in myocardial contraction. Asynergy and its role in congestive heart failure.

TL;DR: The pattern of left ventricular contraction is described as a "series of sequential fractionate contractions of muscle bundles" and the possibility that unco-ordinated contraction of the heart results from a combination of normal and abnormal muscle has received little attention.
Journal ArticleDOI

Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors

TL;DR: Verapamil and D 600 differ in this respect from common local anesthetic compounds such as xylocaine (lidocaine) or procaine which interfere much more with the transmembrane Na conductivity than with the Ca conductivity.
Journal ArticleDOI

Vasodilator therapy of cardiac failure: (first of two parts).

TL;DR: The symptoms of cardiac failure are related to some combination of circulatory congestion and low cardiac output and therapy for cardiac failure has traditionally involved the Administration of an inotropic drug to increase the contractile force of the heart and the administration of a diuretic to increasing the renal excretion of salt and water.
Journal ArticleDOI

Conduction of the Cardiac Impulse

TL;DR: The results prove that conduction delays great enough to permit re-entry can occur in short segments of Purkinje fibers subjected to high K+.
Related Papers (5)